ASX:CYP - Appendix 3Y-Dr Paul Wotton

About us

About us Board of Directors Corporate Governance Company FAQs

Our technology

Cymerus™ Platform Intellectual Property Scientific Publications

Products & Pipeline

Clinical Development Pre-Clinical Development

Investors

ASX Announcements Share Price Investor Presentations Investor FAQs Right to Receive Documents Financial Reports Analyst Research

Appendix 3Y-Dr Paul Wotton

Your question will be sent privately to Cynata Therapeutics. The company may choose to make this question public.

Start the conversation

Ask Cynata Therapeutics a question about this announcement.

Share your feedback

Discover

Cynata Therapeutics

Powered by InvestorHub•Terms and conditions•Privacy policy•Cookie settings•Contact